BIVI - CIK 0001580149
BIOVIE INC. trades as BIVI. This page tracks BIOVIE INC. through 481 SEC filings, with financial statements and metrics updated as new reports are filed.
| Filing | Type | Filed |
|---|---|---|
| Quarterly report | 10-Q | 2026-05-11 |
| SCHEDULE 13D | - | 2026-03-25 |
| Quarterly report | 10-Q | 2026-02-06 |
| Insider trade | 4 | 2026-01-09 |
| Insider trade | 4 | 2026-01-09 |
| Insider trade | 4 | 2026-01-09 |
| Insider trade | 4 | 2026-01-09 |
| Insider trade | 4 | 2026-01-09 |
The largest companies sharing BIOVIE INC.'s SEC industry classification (pharmaceutical preparations).
In its latest fiscal year BIOVIE INC. reported a net loss of $17.54M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.